Antiviral immune responses in H5N1-infected human lung tissue and possible mechanisms underlying the hyperproduction of interferon-inducible protein IP-10.

Biochemical and Biophysical Research Communications
Arunee ThitithanyanontSathit Pichyangkul

Abstract

Information on the immune response against H5N1 within the lung is lacking. Here we describe the sustained antiviral immune responses, as indicated by the expression of MxA protein and IFN-alpha mRNA, in autopsy lung tissue from an H5N1-infected patient. H5N1 infection of primary bronchial/tracheal epithelial cells and lung microvascular endothelial cells induced IP-10, and also up-regulated the retinoic acid-inducible gene-I (RIG-I). Down-regulation of RIG-I gene expression decreased IP-10 response. Co-culturing of H5N1-infected pulmonary cells with TNF-alpha led to synergistically enhanced production of IP-10. In the absence of viral infection, TNF-alpha and IFN-alpha also synergistically enhanced IP-10 response. Methylprednisolone showed only a partial inhibitory effect on this chemokine response. Our findings strongly suggest that both the H5N1 virus and the locally produced antiviral cytokines; IFN-alpha and TNF-alpha may have an important role in inducing IP-10 hyperresponse, leading to inflammatory damage in infected lung.

References

Feb 15, 2001·Journal of Medical Virology·K F ToA F Cheng
Aug 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·G PennaL Adorini
Aug 14, 2002·Biochemistry·Valerie BoothBrian D Sykes
Feb 28, 2004·Lancet·J S M PeirisY Guan
Mar 23, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jennifer M LundRichard A Flavell
Jul 19, 2005·Emerging Infectious Diseases·Mongkol UiprasertkulPrasert Auewarakul
Nov 25, 2006·The New England Journal of Medicine·I Nyoman KandunTimothy M Uyeki
Mar 7, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ronan Le GofficMustapha Si-Tahar
Jul 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mitchell H GraysonMichael J Holtzman
Jul 27, 2007·Journal of Virology·Terrence M TumpeyPeter Staeheli
Oct 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Arunee ThitithanyanontSathit Pichyangkul
Nov 20, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dominik HartlDirk Roos
Feb 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Carole R BaskinMichael G Katze
Apr 13, 2010·Nature Immunology·Takeshi IchinoheAkiko Iwasaki

❮ Previous
Next ❯

Citations

Apr 24, 2013·Journal of Theoretical Biology·Lisa N MurilloAlan S Perelson
Nov 24, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Noriko NakajimaTetsutaro Sata
Jan 25, 2013·Viruses·Irene Ramos, Ana Fernandez-Sesma
Jul 26, 2011·The Journal of Infection·Jan-Erik BerdalChristine M Jonassen
Nov 5, 2014·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Xiaoli LiuLanjuan Li
Oct 16, 2012·Molecular Immunology·Yingjie SunChan Ding
Oct 5, 2016·PloS One·Reena BermanHong Wei Chu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.